Interestingly, IL-17 signaling pathway (KEGG ID: 00030) was closely involved in the immunopathology of autoimmune thyroiditis among these pathways, suggesting that IL-17, the major effector cytokine of Th17 cells, may play a critical role in JYKT administration for autoimmune thyroiditis. The gene discussed is IL17A; the disease is autoimmune thyroid disease.